COVERAGE HUB
$GSK
3 articles in last 30 days
LAST 30 DAYS
3 articles
AVG GRADE
NEUTRAL
score: 0.33
SENTIMENT
NEUTRAL
TOTAL VIEWS
1
3-DAY GRADE TIMELINE
2026-06-11
TODAY
RECENT COVERAGE · 3 ARTICLES
Key deals this week: GSK, Incyte, Ingredion, OpenAI, and more
This week's deal calendar spans multiple sectors with activity in pharmaceuticals, biotech, specialty chemicals, and artificial...
Weekly Buzz: GH, LLY Gain FDA Nod; TEVA, GSK, Lead M&A Wave; ZEAL, LLY Post Strong Data
LLY, TEVA, GSK, and ZEAL are driving a significant biotech rally this week, anchored by multiple FDA and regulatory approvals across...
Nuvalent: 'Hold' On GlaxoSmithKline Acquisition For Selective TKIs (NUVL)
Nuvalent (NUVL) faces a strategic valuation inflection point following GlaxoSmithKline's $10.6 billion acquisition announcement. The...
RELATED TICKERS